Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling
- PMID: 8250835
- PMCID: PMC1137648
- DOI: 10.1042/bj2960015
Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling
Abstract
The beta-isoform of glycogen synthase kinase-3 (GSK3 beta) isolated from rabbit skeletal muscle was inactivated 90-95% following incubation with MgATP and either MAP kinase-activated protein kinase-1 (MAPKAP kinase-1, also termed RSK-2) or p70 S6 kinase (p70S6K), and re-activated with protein phosphatase 2A. MAPKAP kinase-1 and p70S6K phosphorylated the same tryptic peptide on GSK3 beta, and the site of phosphorylation was identified as the serine located nine residues from the N-terminus of the protein. The inhibitory effect of Ser-9 phosphorylation on GSK3 beta activity was observed with three substrates, (inhibitor-2, c-jun and a synthetic peptide), and also with glycogen synthase provided that 0.15 M KCl was added to the assays. The results suggest that Ser-9 phosphorylation underlies the reported inhibition of GSK3 beta by insulin and that GSK3 may represent a point of convergence of two major growth-factor-stimulated protein kinase cascades.
Similar articles
-
The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro.FEBS Lett. 1994 Jan 24;338(1):37-42. doi: 10.1016/0014-5793(94)80112-6. FEBS Lett. 1994. PMID: 8307153
-
Inactivation of MAP kinases.Trends Biochem Sci. 1994 Jan;19(1):1-2. doi: 10.1016/0968-0004(94)90163-5. Trends Biochem Sci. 1994. PMID: 8140614 Review. No abstract available.
-
The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf.Biochem J. 1994 Oct 1;303 ( Pt 1)(Pt 1):21-6. doi: 10.1042/bj3030021. Biochem J. 1994. PMID: 7945242 Free PMC article.
-
An emerging family of dual specificity MAP kinase phosphatases.Biochim Biophys Acta. 1995 Mar 16;1265(2-3):152-60. doi: 10.1016/0167-4889(94)00211-v. Biochim Biophys Acta. 1995. PMID: 7696343 Review. No abstract available.
-
Phosphorylation and activation of the ATP-Mg-dependent protein phosphatase by the mitogen-activated protein kinase.J Biol Chem. 1995 Aug 4;270(31):18352-8. doi: 10.1074/jbc.270.31.18352. J Biol Chem. 1995. PMID: 7629158
Cited by
-
Conversion of dendritic cells into tolerogenic or inflammatory cells depends on the activation threshold and kinetics of the mTOR signaling pathway.Cell Commun Signal. 2024 May 21;22(1):281. doi: 10.1186/s12964-024-01655-1. Cell Commun Signal. 2024. PMID: 38773618 Free PMC article.
-
Insulin signaling and pharmacology in humans and in corals.PeerJ. 2024 Jan 31;12:e16804. doi: 10.7717/peerj.16804. eCollection 2024. PeerJ. 2024. PMID: 38313028 Free PMC article.
-
The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds.Int J Mol Sci. 2023 Nov 28;24(23):16854. doi: 10.3390/ijms242316854. Int J Mol Sci. 2023. PMID: 38069175 Free PMC article. Review.
-
Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease.Mol Neurobiol. 2024 Jul;61(7):4203-4221. doi: 10.1007/s12035-023-03839-1. Epub 2023 Dec 8. Mol Neurobiol. 2024. PMID: 38064104 Review.
-
Network pharmacology‑based investigation of potential targets of triptonodiol acting on non-small-cell lung cancer.Eur J Med Res. 2023 Nov 28;28(1):547. doi: 10.1186/s40001-023-01453-4. Eur J Med Res. 2023. PMID: 38017514 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous